Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dihydroquercetin
1. (+)-taxifolin
2. 480-18-2
3. Dihydroquercetin
4. Distylin
5. Taxifoliol
6. (2r,3r)-dihydroquercetin
7. 24198-97-8
8. (+)-dihydroquercetin
9. Lavitol
10. (+/-)-taxifolin
11. Taxifolin-(+)
12. 17654-26-1
13. Diquertin
14. Lariksin
15. 2,3-dihydroquercetin
16. Flamena D
17. (2r,3r)-3,3',4',5,7-pentahydroxyflavanone
18. (2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one
19. (2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one
20. Taxifolin (dihydroquercetin)
21. 3,5,7,3',4'-pentahydroxyflavanone
22. (2r,3r)-(+)-taxifolin
23. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2r,3r)-
24. (+/-)-dihydroquercetin
25. Taxifolin, (+/-)-
26. (2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4h-chromen-4-one
27. Eas93sc1vs
28. Dihydroquercetin, (+/-)-
29. (2r-trans)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4-benzopyrone
30. Flavanone, 3,3',4',5,7-pentahydroxy-
31. Chebi:17948
32. (+)-(2r,3r)-dihydroquercetin
33. 9sob9e3987
34. (?)-taxifolin
35. (2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-one
36. Rel-(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one
37. (2r,3r)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4h-1-benzopyran-4-one
38. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2r-trans)-
39. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, Trans-(+/-)-
40. Dqh
41. Smr000466389
42. Trans-dihydroquercetin
43. (+)-trans-taxifolin
44. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-
45. (+/-)-taxifolin Hydrate
46. Unii-9sob9e3987
47. Ccris 9292
48. Taxifolin (tax)
49. Einecs 207-543-4
50. Mfcd00006845
51. Flamena
52. (+)-trans Taxifolin
53. (2r,3r)-trans-dihydroquercetin
54. Brn 0093548
55. (2r,3r)-taxifolin
56. Unii-eas93sc1vs
57. (+/-)-trans Taxifolin
58. Schembl39786
59. 5-18-05-00451 (beilstein Handbook Reference)
60. Mls000759539
61. Mls001066341
62. Mls001074712
63. Mls001424044
64. Mls002153142
65. Bidd:er0483
66. Taxifolin, Analytical Standard
67. Flavone, 2,3-dihydro-3,3',4',5,7-pentahydroxy-
68. Dihydroquercetin [inci]
69. Megxp0_000741
70. Dtxsid8022450
71. Acon1_000239
72. Dihydroquercetin [who-dd]
73. Bdbm212435
74. Dtxsid301017215
75. Hms2051m22
76. Hms2234l14
77. Hy-n0136
78. Ac-935
79. S2366
80. Akos015965399
81. Zinc100018343
82. Ccg-100909
83. Cs-3365
84. Db02224
85. Ks-1312
86. Nc00159
87. Ncgc00016024-08
88. Ncgc00180750-01
89. 20254-28-8
90. As-17723
91. Dihydroquercetin, (+)-(2r,3r)-
92. Sw197539-2
93. T3666
94. C01617
95. (2r,3r)-3,5,7,3',4'-pentahydroxyflavanone
96. Q412191
97. Sr-01000759385
98. Flavanone, 3,3',4',5,7-pentahydroxy-, (r,r)-
99. J-011205
100. Sr-01000759385-6
101. Taxifolin, Primary Pharmaceutical Reference Standard
102. F40ab773-26fa-4112-a46d-dc970af64bc1
103. Flavanone, 3,3',4',5,7-pentahydroxy-, (2r)-trans-
104. Flavanone, 3,3',4',5,7-pentahydroxy-, Trans-(+)-
105. (+)-taxifolin (constituent Of Maritime Pine) [dsc]
106. (+)-taxifolin (constituent Of Milk Thistle) [dsc]
107. Flavanone, 3,3',4',5,7-pentahydroxy-, (2r,3r)-(+)-
108. 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4h-chromen-4-one, (2r-trans)-
109. 4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-,(2r,3r)-rel-
Molecular Weight | 304.25 g/mol |
---|---|
Molecular Formula | C15H12O7 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 1 |
Exact Mass | 304.05830272 g/mol |
Monoisotopic Mass | 304.05830272 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 428 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Taxifolin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Taxifolin, including repackagers and relabelers. The FDA regulates Taxifolin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Taxifolin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Taxifolin supplier is an individual or a company that provides Taxifolin active pharmaceutical ingredient (API) or Taxifolin finished formulations upon request. The Taxifolin suppliers may include Taxifolin API manufacturers, exporters, distributors and traders.
Taxifolin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Taxifolin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Taxifolin GMP manufacturer or Taxifolin GMP API supplier for your needs.
A Taxifolin CoA (Certificate of Analysis) is a formal document that attests to Taxifolin's compliance with Taxifolin specifications and serves as a tool for batch-level quality control.
Taxifolin CoA mostly includes findings from lab analyses of a specific batch. For each Taxifolin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Taxifolin may be tested according to a variety of international standards, such as European Pharmacopoeia (Taxifolin EP), Taxifolin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Taxifolin USP).
LOOKING FOR A SUPPLIER?